alexa Mycobacterium Tuberculosis Drug

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Webinars & Conferences

Advancement on Fungal Infections 2020

New York, USA

Mycobacterium Tuberculosis Drug

TB is one of the oldest known infectious diseases, and today still remains an important health problem both worldwide and in our country. World Health Organization [WHO] estimates that one third of world™s population is infected by M. tuberculosis. There were nearly 8.6 million cases around the world in 2012 and approximately 1.3 million of them died. TB incidence was 122 per 100,000 population, while global TB prevalence was 169 per 100,000 population in 2012. According to the 2012 report of TB Control Department in Turkey, the number of cases registered in 2010 was 16551 and TB incidence was 24 per 100 000 population, while the number of new cases was 15183. In recent years, a dramatic increase in the emergence of MDR-TB and XDR-TB cases has been observed. Globally drug resistance is a major concern for global health.
  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger

Last date updated on October, 2020